Freebird Partners LP

10% OwnerEterna Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Dec 18, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2023Buy(P)521K$1.92$1.0M783K
Dec 15, 2023Buy(P)1.0M2.0M
Dec 14, 2023Grant(A)524K949K
Dec 14, 2023Disposed to issuer(D)524K425K
Dec 14, 2023Grant(A)425K949K
Dec 14, 2023Disposed to issuer(D)425K524K

Transaction Codes

P
Open-market purchase
A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-071263) within minutes of acceptance. Every field above traces to the original document. Verify it directly: